Portable Ultrasound to Predict Heart Failure Readmission Risk

Heart Failure Clinical Trial

Official title:

Utility and Feasibility of Prehospital Portable Ultrasound to Predict Heart Failure Readmission Risk

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05980533
• Other study ID #: 2307-41
• Status: Not yet recruiting
• Phase: N/A
• Start date: December 30, 2024
• Est. completion date: December 30, 2026

Study information

• Verified date: February 2024
• Source: The Guthrie Clinic
• Contact: Zachary Dewar, MD
• Phone: 570-887-4882
• Email: Zachary.Dewar[@]guthrie.org
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this research is to use a handheld ultrasound to assess patients with congestive heart failure (CHF) to see if the ultrasound can help predict readmission to the hospital. The study will include patients who are admitted to the hospital for CHF. Participants will have two ultrasounds at hospital discharge and at a follow up visit.

Description:

The purpose of this research is to see if a portable ultrasound can help predict readmission to the hospital for patients who are admitted to the hospital for CHF. The study will enroll patients who take part in Mobile Integrated Healthcare as part of their routine care. Participants will have two ultrasounds. The first ultrasound will be at hospital discharge.

Between seven to ten days after hospital discharge participants will be visited at their home in follow-up as the usual standard of care for Mobile Integrated Healthcare. At this visit participants will have a second ultrasound. Participants will be followed for one year for hospital readmission.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 50
• Est. completion date: December 30, 2026
• Est. primary completion date: December 30, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Primary admission diagnosis is listed as congestive heart failure, with an acute component of decompensation.

• Age greater than 18 years.

• Principal residence within the geographic reach of our MIH program.

Exclusion Criteria:

• pregnant women

Related Conditions & MeSH terms

• Heart Failure
• Patient Readmission

Intervention

Diagnostic Test:
• Ultrasound
Ultrasound at hospital discharge and at follow up at 7-10 days

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
The Guthrie Clinic

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hospital Readmission	Hospital readmission within 30 days of discharge	30 days